[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100647054":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":31,"responsibleParty":45,"collaborators":20,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":20,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":73,"whyStopped":20,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Atlas University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"ESWT","EXPERIMENTAL","Participants with lipedema will receive extracorporeal shock wave therapy (ESWT) administered three times per week for two consecutive weeks, for a total of six treatment sessions.",[13],"Device: Extracorporeal Shock Wave Therapy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Extracorporeal Shock Wave Therapy","Extracorporeal shock wave therapy (ESWT) will be applied to affected lower-extremity regions using a CE-marked shock wave device. Participants will receive six treatment sessions administered three times per week for two consecutive weeks. Clinical and ultrasonographic assessments will be performed before and after treatment.",[9],null,[22],{"name":23,"affiliation":24,"role":25},"Elif Ozyigit, MD","University of Health Sciences, Kanuni Sultan Suleyman Training and Research Hospital","PRINCIPAL_INVESTIGATOR",[27],{"name":23,"role":28,"phone":29,"phoneExt":20,"email":30},"CONTACT","+902124041500","dr.elifoz16@gmail.com",[32],{"facility":33,"status":20,"city":34,"state":34,"zip":20,"country":35,"countryCode":20,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Kanuni Sultan Suleyman Training and Research Hospital","Istanbul","Turkey (Türkiye)",{"type":37,"coordinates":38},"Point",[39,40],28.94966,41.01384,{"lat":40,"lon":39},[43,44],{"name":23,"role":28,"phone":29,"phoneExt":20,"email":30},{"name":23,"role":25,"phone":20,"phoneExt":20,"email":20},{"type":46,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100647054","extracorporeal-shock-wave-therapy-in-patients-with-lipedema-100647054",false,"NCT07683559","Extracorporeal Shock Wave Therapy in Patients With Lipedema","Evaluation of the Effects of Extracorporeal Shock Wave Therapy on Pain, Quality of Life, and Ultrasonographic Findings in Patients With Lipedema","LIPO-ESWT","Inclusion Criteria:\n\n* Male or female participants aged 18 to 75 years\n* Clinical diagnosis of lipedema\n* Willingness to participate and provide written informed consent\n* Ability to comply with study procedures and follow-up assessments\n\nExclusion Criteria:\n\n* Pregnancy or breastfeeding\n* Active infection in the treatment area\n* Malignancy\n* Severe cardiovascular disease\n* Coagulation disorders or current anticoagulant therapy\n* Previous ESWT treatment within the last 6 months\n* Severe psychiatric or cognitive disorders interfering with study participation\n* Any condition deemed by the investigator to make participation unsafe","ALL","18 Years","75 Years",{"count":59,"type":60},40,"ESTIMATED","INTERVENTIONAL",[63],"NA","Lipedema is a chronic adipose tissue disorder characterized by pain, tenderness, disproportionate fat accumulation, and impaired quality of life. Extracorporeal shock wave therapy (ESWT) has been proposed as a non-invasive treatment option that may improve pain and tissue characteristics in patients with lipedema.\n\nThe aim of this prospective interventional study is to evaluate the effects of ESWT on pain intensity, quality of life, functional outcomes, and ultrasonographic findings in patients diagnosed with lipedema. Participants will receive a standardized ESWT protocol consisting of six treatment sessions over a two-week period. Clinical assessments and ultrasonographic examinations will be performed before and after treatment.",[66],"Lipedema",[17,9,66,68,69,70,71,72],"Pain","Ultrasonography","Quality of Life","PROMIS","Patient-Reported Outcomes","NOT_YET_RECRUITING","2026-07-01",{"date":76,"type":77},"2026-07-06","ACTUAL",{"date":74,"type":60},{"date":80,"type":60},"2027-01-01",{"name":5,"class":6},1]